ROVI.MCROVI.MCBME
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -15.13% | +2.46% | -10.36% | -10.54% | +9.68% |
| Gross Profit Growth | +103.78% | +5.52% | -4.56% | -9.49% | -53.69% |
| EBITDA Growth | -45.30% | +18.53% | -21.09% | -13.90% | +57.76% |
| Operating Income Growth | -50.71% | +19.29% | -24.89% | -15.32% | +66.72% |
| Net Income Growth | -54.59% | +20.99% | -26.37% | -16.08% | +82.47% |
| EPS Growth | +82.83% | +20.69% | -23.64% | -13.08% | -54.14% |
| EPS Diluted Growth | +82.83% | +20.69% | -23.64% | -13.08% | -54.14% |
| Weighted Average Shares Growth | -1.34% | -0.33% | -4.18% | -4.18% | +0.05% |
| Weighted Average Shares Diluted Growth | -1.34% | -0.33% | -4.18% | -4.18% | +0.05% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +19.82% | +21.23% | -35.37% | +107.23% | +16.75% |
| Free Cash Flow Growth | +37.08% | +61.28% | -174.76% | +175.30% | +28.13% |
| Receivables Growth | -9.64% | -11.61% | +12.78% | +3.17% | +37.12% |
| Inventory Growth | -2.37% | -5.49% | -7.83% | -9.20% | -12.72% |
| Asset Growth | +4.02% | +4.53% | +1.43% | +5.04% | +14.86% |
| Book Value per Share Growth | +7.49% | +13.88% | +23.55% | +18.25% | +16.09% |
| Debt Growth | +74.87% | +32.54% | +6.72% | -3.63% | +27.69% |
| R&D Expense Growth | +4.69% | +0.00% | +68.36% | +51.20% | +48.97% |
| SG&A Expenses Growth | +5.70% | +0.00% | +83.78% | +94.07% | +4.27% |